Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome

被引:260
作者
van der Hilst, Jeroen C. H. [1 ]
Bodar, Evelien J. [1 ]
Barron, Karyl S. [5 ]
Frenkel, Joost [3 ,4 ]
Drenth, Joost P. H. [2 ]
van der Meer, Jos W. M. [1 ]
Simon, Anna [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Med Ctr, Div Pediat, Dept Gen Pediat, Utrecht, Netherlands
[4] Univ Med Ctr, Div Pediat, Dept Pediat Immunol, Utrecht, Netherlands
[5] NIAID, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1097/MD.0b013e318190cfb7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The hyperimmunoglobulinemia D and periodic fever syndrome (HIDS). one of the autoinflammatory syndromes, is caused by Mutations in the gene coding for mevalonate kinase (MVK). We conducted the current study to assess the genetic, laboratory, and clinical features as well as the complications and course of disease in patients with genetically confirmed HIDS. fit addition. we studied the quality of lite Mid Course of life in a selection of patients. Follow-up data were obtained by a questionnaire sent to all physicians of patients in the international HIDS Database. In addition. we assessed the course of life and quality of life in Dutch patients aged >16 years using validated quality of life instruments. Data were obtained from 103 patients from 18 different countries. The median age of first attack was 6 months (rang-c. 0-120 mo). with a median period of 9.9 years from onset of disease to diagnosis. The most frequent symptoms that accompanied attacks of fever were lymphadenopathy, abdominal pain, arthralgia, diarrhea. vomiting, skin lesions, and aphthous ulcers. Amyloidosis was a severe but infrequent complication (2.9%). The median serum IgD level was 400 U/mL. IgD levels were normal in 22%, of patients. The 4 most prevalent Mutations (V3771, 1268T, H20P/N, P167L) accounted for 71.5% of mutations found. The frequency Of attacks decreased with the patient's increasing age, although 50% of patients over the age of 20 years still had 6 or more attacks per year. Many drugs have been tried in HIDS. Some patients responded to high-close prednisone (24.4% response). Anakinra and etanercept can also be effective (33.3% response). Quality of life was determined in a Subgroup of patients (n = 28). Social functioning, general health perception, and vitality were significantly lower in patients with HIDS than in controls, as were autonomy and social development. In addition, HIDS had all adverse impact oil educational achievements and employment status. In conclusion, HIDS is ail early-onset disease that is accompanied by in array of inflammatory symptoms. Although the frequently of attacks decreases during the patient's life, many patients continue to have frequent attacks. HIDS impairs several aspects of quality of life.
引用
收藏
页码:301 / 310
页数:10
相关论文
共 40 条
[1]   Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome [J].
Ammouri, W. ;
Cuisset, L. ;
Rouaghe, S. ;
Rolland, M.-O. ;
Delpech, M. ;
Grateau, G. ;
Ravet, N. .
RHEUMATOLOGY, 2007, 46 (10) :1597-1600
[2]   Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept [J].
Arkwright, PD ;
McDermottt, MF ;
Houten, SM ;
Frenkel, J ;
Waterhan, HR ;
Aganna, E ;
Hammond, LJ ;
Mirakian, RM ;
Tomlin, P ;
Vijaydurai, PI ;
Cant, AJ .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (03) :484-488
[3]  
Bodar EJ, 2005, NETH J MED, V63, P260
[4]   Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome [J].
Bodar, Evelien J. ;
van der Hilst, Jeroen C. H. ;
van Heerde, Waander ;
van der Meer, Jos W. M. ;
Drenth, Joost P. H. ;
Simon, Anna .
BLOOD, 2007, 109 (06) :2416-2418
[5]  
Buskila D, 1997, CLIN EXP RHEUMATOL, V15, P355
[6]   Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis [J].
Cailliez, M. ;
Garaix, F. ;
Rousset-Rouviere, C. ;
Bruno, D. ;
Kone-Paut, I. ;
Sarles, J. ;
Chabrol, B. ;
Tsimaratos, M. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 (06) :763-763
[7]   Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome [J].
Cuisset, L ;
Drenth, JP ;
Simon, A ;
Vincent, MF ;
Visser, SV ;
van der Meer, JWM ;
Grateau, G ;
Delpech, M .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (04) :260-266
[8]   Mevalonate kinase deficiency in a child with periodic fever and without hyperimmunoglobulinaemia D [J].
Di Rocco, M ;
Caruso, U ;
Waterham, HR ;
Picco, P ;
Loy, A ;
Wanders, RJA .
JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 (03) :411-412
[9]   The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome [J].
Dodé, C ;
André, M ;
Bienvenu, T ;
Hausfater, P ;
Pêcheux, C ;
Bienvenu, J ;
Lecron, JC ;
Reinert, P ;
Cattan, D ;
Piette, JC ;
Szajnert, MF ;
Delpech, M ;
Grateau, G .
ARTHRITIS AND RHEUMATISM, 2002, 46 (08) :2181-2188
[10]   HYPERIMMUNOGLOBULINEMIA-D AND PERIODIC FEVER SYNDROME - THE CLINICAL SPECTRUM IN A SERIES OF 50 PATIENTS [J].
DRENTH, JPH ;
HAAGSMA, CJ ;
VANDERMEER, JWM ;
WEEMAES, CMR ;
BIJLSMA, JWJ ;
DEGRAEFFMEEDER, ER ;
ALCALAY, M ;
CHAPELONABRIC, C ;
KAHN, MF ;
PRIEUR, AM ;
SIBILIA, J ;
POWELL, RJ ;
TOPALOGLU, R ;
SAATCI, U ;
SCOLOZZI, R ;
LAZZARIN, P ;
MONCIOTTI, CM ;
DEMONTY, J ;
JILEK, D ;
MIYAGAWA, S ;
ESPANOL, T .
MEDICINE, 1994, 73 (03) :133-144